Autism Spectrum Disorder Therapeutics Market Size, Share & Industry Analysis By Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Others), By Treatment Type (Communication & Behavioral Therapies, Drug Therapies), and Regional Forecast 2019-2026

Table of Content:

1. Introduction

    1.1. Research Scope

    1.2. Market Segmentation

    1.3. Research Methodology

    1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

    3.1. Market Drivers

    3.2. Market Restraints

    3.3. Market Opportunities

4. Key Insights

    4.1. Prevalence of Autism Spectrum Disorder for Key Countries/Region

    4.2. Recent Industry Developments Such As Partnerships, Mergers, & Acquisitions

    4.3. Regulatory Framework by Key Countries

    4.4. Global Reimbursement Scenario and Economic Cost Burden for the Treatment of Autism Spectrum Disorder by Key Countries/Region

5. Global Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026

    5.1. Key Findings / Summary

    5.2. Market Analysis, Insights and Forecast – By Type

        5.2.1. Autistic Disorder

        5.2.2. Asperger Syndrome

        5.2.3. Pervasive Developmental Disorder

        5.2.4. Others

    5.3. Market Analysis, Insights and Forecast – By Treatment Type

        5.3.1. Communication & Behavioral Therapies

            5.3.1.1. Applied behavior analysis (ABA)

            5.3.1.2. Speech & Language Therapy

            5.3.1.3. Occupational Therapy

            5.3.1.4. Others

        5.3.2. Drug Therapies

            5.3.2.1. Antipsychotic Drugs

            5.3.2.2. SSRIS

            5.3.2.3. Stimulants

            5.3.2.4. Sleep Medications

            5.3.2.5. Others

    5.4. Market Analysis, Insights and Forecast – By Region

        5.4.1. North America

        5.4.2. Europe

        5.4.3. Asia pacific

        5.4.4. Latin America

        5.4.5. Middle East & Africa

6. North America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026

    6.1. Key Findings / Summary

    6.2. Market Analysis – By Type

        6.2.1. Autistic Disorder

        6.2.2. Asperger Syndrome

        6.2.3. Pervasive Developmental Disorder

        6.2.4. Others

    6.3. Market Analysis – By Treatment Type

        6.3.1. Communication & Behavioral Therapies

            6.3.1.1. Applied behavior analysis (ABA)

            6.3.1.2. Speech & Language Therapy

            6.3.1.3. Occupational Therapy

            6.3.1.4. Others

        6.3.2. Drug Therapies

            6.3.2.1. Antipsychotic Drugs

            6.3.2.2. SSRIS

            6.3.2.3. Stimulants

            6.3.2.4. Sleep Medications

            6.3.2.5. Others

    6.4. Market Analysis – By Country

        6.4.1. U.S.

        6.4.2. Canada

7. Europe Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026

    7.1. Key Findings / Summary

    7.2. Market Analysis – By Type

        7.2.1. Autistic Disorder

        7.2.2. Asperger Syndrome

        7.2.3. Pervasive Developmental Disorder

        7.2.4. Others

    7.3. Market Analysis – By Treatment Type

        7.3.1. Communication & Behavioral Therapies

            7.3.1.1. Applied behavior analysis (ABA)

            7.3.1.2. Speech & Language Therapy

            7.3.1.3. Occupational Therapy

            7.3.1.4. Others

        7.3.2. Drug Therapies

            7.3.2.1. Antipsychotic Drugs

            7.3.2.2. SSRIS

            7.3.2.3. Stimulants

            7.3.2.4. Sleep Medications

            7.3.2.5. Others

    7.4. Market Analysis – By Country/Sub-region

        7.4.1. U.K.

        7.4.2. Germany

        7.4.3. France

        7.4.4. Spain

        7.4.5. Italy

        7.4.6. Scandinavia

        7.4.7. Rest of Europe

8. Asia Pacific Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026

    8.1. Key Findings / Summary

    8.2. Market Analysis – By Type

        8.2.1. Autistic Disorder

        8.2.2. Asperger Syndrome

        8.2.3. Pervasive Developmental Disorder

        8.2.4. Others

    8.3. Market Analysis – By Treatment Type

        8.3.1. Communication & Behavioral Therapies

            8.3.1.1. Applied behavior analysis (ABA)

            8.3.1.2. Speech & Language Therapy

            8.3.1.3. Occupational Therapy

            8.3.1.4. Others

        8.3.2. Drug Therapies

        8.3.3. Antipsychotic Drugs

            8.3.3.1. SSRIS

            8.3.3.2. Stimulants

            8.3.3.3. Sleep Medications

            8.3.3.4. Others

    8.4. Market Analysis – By Country/Sub-region

        8.4.1. Japan

        8.4.2. China

        8.4.3. India

        8.4.4. Australia

        8.4.5. Southeast Asia

        8.4.6. Rest of Asia Pacific

9. Latin America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026

    9.1. Key Findings / Summary

    9.2. Market Analysis – By Type

        9.2.1. Autistic Disorder

        9.2.2. Asperger Syndrome

        9.2.3. Pervasive Developmental Disorder

        9.2.4. Others

    9.3. Market Analysis – By Treatment Type

        9.3.1. Communication & Behavioral Therapies

            9.3.1.1. Applied behavior analysis (ABA)

            9.3.1.2. Speech & Language Therapy

            9.3.1.3. Occupational Therapy

            9.3.1.4. Others

        9.3.2. Drug Therapies

            9.3.2.1. Antipsychotic Drugs

            9.3.2.2. SSRIS

            9.3.2.3. Stimulants

            9.3.2.4. Sleep Medications

            9.3.2.5. Others

    9.4. Market Analysis – By Country/Sub-region

        9.4.1. Brazil

        9.4.2. Mexico

        9.4.3. Rest of Latin America

10. Middle East & Africa Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026

    10.1. Key Findings / Summary

    10.2. Market Analysis – By Type

        10.2.1. Autistic Disorder

        10.2.2. Asperger Syndrome

        10.2.3. Pervasive Developmental Disorder

        10.2.4. Others

    10.3. Market Analysis – By Treatment Type

        10.3.1. Communication & Behavioral Therapies

            10.3.1.1. Applied behavior analysis (ABA)

            10.3.1.2. Speech & Language Therapy

            10.3.1.3. Occupational Therapy

            10.3.1.4. Others

        10.3.2. Drug Therapies

            10.3.2.1. Antipsychotic Drugs

            10.3.2.2. SSRIS

            10.3.2.3. Stimulants

            10.3.2.4. Sleep Medications

            10.3.2.5. Others

    10.4. Market Analysis – By Country/Sub-region

        10.4.1. GCC Countries

        10.4.2. South Africa

        10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

    11.1. Key Industry Developments

    11.2. Global Market Share Analysis (2018)

    11.3. Competition Dashboard

    11.4. Comparative Analysis – Major Players

    11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))

        11.5.1. Allergan

        11.5.2. Q BioMed Inc

        11.5.3. Hopebridge, LLC.

        11.5.4. Center for Autism and Related Disorders

        11.5.5. Behavior Innovations

        11.5.6. Applied Behavior Consultants

        11.5.7. Fusion Autism Center

        11.5.8. Otsuka Holdings Co. Ltd.

        11.5.9. AstraZeneca

        11.5.10. Pfizer Inc.

        11.5.11. Eli Lilly and Company

        11.5.12. Johnson & Johnson Services, Inc.

12. Strategic Recommendations